Sangamo Therapeutics (NASDAQ:SGMO) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
Sangamo Therapeutics beat estimated earnings by 17.14%, reporting an EPS of $-0.29 versus an estimate of $-0.35.
Revenue was up $1.51 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 3.72% drop in the share price the next day.
Here’s a look at Sangamo Therapeutics’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.31 | -0.34 | -0.34 | -0.31 |
| EPS Actual | -0.30 | -0.26 | -0.33 | -0.33 |
| Revenue Estimate | 27.29M | 26.82M | 25.19M | 26.48M |
| Revenue Actual | 28.23M | 27.99M | 28.56M | 27.87M |
To track all earnings releases for Sangamo Therapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
